FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:251-257 January 23, 1997 Number 4 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background In patients who have had a myocardial infarction, the long-term risk of stroke and its relation to the extent of left ventricular dysfunction have not been determined. We studied whether a reduced left ventricular ejection fraction is associated with an increased risk of stroke after myocardial infarction and whether other factors such as older age and therapy with anticoagulants, thrombolytic agents, or captopril affect long-term rates of stroke.

Methods We performed an observational analysis of prospectively collected data on 2231 patients who had left ventricular dysfunction after acute myocardial infarction who were enrolled in the Survival and Ventricular Enlargement trial. The mean follow-up was 42 months. Risk factors for stroke were assessed by both univariate and multivariate Cox proportional-hazards analysis.

Results Among these patients, 103 (4.6 percent) had fatal or nonfatal strokes during the study (rate of stroke per year of follow-up, 1.5 percent). The estimated five-year rate of stroke in all the patients was 8.1 percent. As compared with patients without stroke, patients with stroke were older (mean [±SD] age, 63±9 years vs. 59±11 years; P<0.001) and had lower ejection fractions (29±7 percent vs. 31±7 percent, P = 0.01). Independent risk factors for stroke included a lower ejection fraction (for every decrease of 5 percentage points in the ejection fraction there was an 18 percent increase in the risk of stroke), older age, and the absence of aspirin or anticoagulant therapy. Patients with ejection fractions of <28 percent after myocardial infarction had a relative risk of stroke of 1.86, as compared with patients with ejection fractions of >35 percent (P = 0.01). The use of thrombolytic agents and captopril had no significant effect on the risk of stroke.

Conclusions During the five years after myocardial infarction, patients have a substantial risk of stroke. A decreased ejection fraction and older age are both independent predictors of an increased risk of stroke. Anticoagulant therapy appears to have a protective effect against stroke after myocardial infarction.

Source Information

From the Hospital of the University of Pennsylvania, Philadelphia (E.L., M.S.S.); the University of Texas Health Science Center, Houston (C.-C.C.W., L.A.M.); Montreal Heart Institute, Montreal (J.L.R.); the University of Missouri Hospital and Clinics, Columbia (G.C.F.); the University of Maryland Hospital, Baltimore (S.S.G.); Mt. Sinai Medical Center, Miami Beach, Fla. (G.A.L.); and Brigham and Women's Hospital, Boston (S.Z.G., M.A.P.).

Address reprint requests to Dr. Loh at the Hospital of the University of Pennsylvania, 9 Founders Pavilion, 3400 Spruce St., Philadelphia, PA 19104.

Full Text of this Article

Related Letters:

Risk of Stroke after Myocardial Infarction
Michaels A. D., Gambassi G., Carbonin P., Bernabei R., Loh E., Moyé L. A., Pfeffer M. A.
Extract | Full Text  
N Engl J Med 1997; 336:1916-1917, Jun 26, 1997. Correspondence

This article has been cited by other articles:

• Meseguer, E., Labreuche, J., Durdilly, C., Echeverria, A., Lavallee, P. C., Ducrocq, G., Touboul, P.-J., Steg, P. G., Amarenco, P. (2010). Prevalence of Embolic Signals in Acute Coronary Syndromes. Stroke 41: 261-266 [Abstract] [Full Text]  
• Ferrari, J., Knoflach, M., Kiechl, S., Willeit, J., Schnabl, S., Seyfang, L., Lang, W., For the Austrian Stroke Unit Registry Collaborator, (2010). Early clinical worsening in patients with TIA or minor stroke: The Austrian Stroke Unit Registry. Neurology 74: 136-141 [Abstract] [Full Text]  
• Ng, T. M.H., Tsai, F., Khatri, N., Barakat, M. N., Elkayam, U. (2010). Venous Thromboembolism in Hospitalized Patients With Heart Failure: Incidence, Prognosis, and Prevention. Circ Heart Fail 3: 165-173 [Full Text]  
• Pullicino, P. M., McClure, L. A., Wadley, V. G., Ahmed, A., Howard, V. J., Howard, G., Safford, M. M. (2009). Blood Pressure and Stroke in Heart Failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Stroke 40: 3706-3710 [Abstract] [Full Text]  
• Schafer, A., Fraccarollo, D., Widder, J., Eigenthaler, M., Ertl, G., Bauersachs, J. (2009). Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer. Eur J Heart Fail 11: 336-341 [Abstract] [Full Text]  
• Ripley, T. L., Nutescu, E. (2009). Anticoagulation in patients with heart failure and normal sinus rhythm. Am J Health Syst Pharm 66: 134-141 [Abstract] [Full Text]  
• Diener, H.-C., Mattle, H., Böhm, M., Ruschitzka, F. (2009). CHAPTER 15a The Heart and the Brain. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Weinsaft, J. W., Kim, H. W., Shah, D. J., Klem, I., Crowley, A. L., Brosnan, R., James, O. G., Patel, M. R., Heitner, J., Parker, M., Velazquez, E. J., Steenbergen, C., Judd, R. M., Kim, R. J. (2008). Detection of Left Ventricular Thrombus by Delayed-Enhancement Cardiovascular Magnetic Resonance: Prevalence and Markers in Patients With Systolic Dysfunction. J Am Coll Cardiol 52: 148-157 [Abstract] [Full Text]  
• Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A. (2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 776S-814S [Abstract] [Full Text]  
• Aull-Watschinger, S., Konstantin, H., Demetriou, D., Schillinger, M., Habicht, A., Horl, W. H., Watschinger, B. (2008). Pre-transplant predictors of cerebrovascular events after kidney transplantation. Nephrol Dial Transplant 23: 1429-1435 [Abstract] [Full Text]  
• Doufekias, E., Segal, A. Z., Kizer, J. R. (2008). Cardiogenic and aortogenic brain embolism.. J Am Coll Cardiol 51: 1049-1059 [Abstract] [Full Text]  
• Weir, N U (2008). An update on cardioembolic stroke. Postgrad. Med. J. 84: 133-142 [Abstract] [Full Text]  
• Coca, A., Messerli, F. H., Benetos, A., Zhou, Q., Champion, A., Cooper-DeHoff, R. M., Pepine, C. J. (2008). Predicting Stroke Risk in Hypertensive Patients With Coronary Artery Disease: A Report From the INVEST. Stroke 39: 343-348 [Abstract] [Full Text]  
• de Boer, R. A., van Veldhuisen, D. J. (2008). Letter by de Boer and van Veldhuisen Regarding Article, "Risk of Thromboembolism in Heart Failure: An Analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)". Circulation 117: e7-e7 [Full Text]  
• Schneider, D. J., Sobel, B. E. (2007). Conundrums in the Combined Use of Anticoagulants and Antiplatelet Drugs. Circulation 116: 305-315 [Full Text]  
• Freudenberger, R. S., Hellkamp, A. S., Halperin, J. L., Poole, J., Anderson, J., Johnson, G., Mark, D. B., Lee, K. L., Bardy, G. H., for the SCD-HeFT Investigators, (2007). Risk of Thromboembolism in Heart Failure: An Analysis From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 115: 2637-2641 [Abstract] [Full Text]  
• Sampson, U. K., Pfeffer, M. A., McMurray, J. J.V., Lokhnygina, Y., White, H. D., Solomon, S. D., for the Valsartan in Acute Myocardial iNfarcTion (, (2007). Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial. Eur Heart J 28: 685-691 [Abstract] [Full Text]  
• Chong, A.-Y., Lip, G. Y.H. (2007). Viewpoint: The prothrombotic state in heart failure: A maladaptive inflammatory response?. Eur J Heart Fail 9: 124-128 [Abstract] [Full Text]  
• Van De Graaff, E., Dutta, M., Das, P., Shry, E. A., Frederick, P. D., Blaney, M., Pasta, D. J., Steinhubl, S. R. (2006). Early Coronary Revascularization Diminishes the Risk of Ischemic Stroke With Acute Myocardial Infarction. Stroke 37: 2546-2551 [Abstract] [Full Text]  
• Suarez, J. I. (2006). Acute Myocardial Infarction, Ischemic Stroke, Sympathetic Stress, and Inflammation: Birds of a Feather. Stroke 37: 2449-2450 [Full Text]  
• Nair, A., Sealove, B., Halperin, J. L., Webber, G., Fuster, V. (2006). Anticoagulation in patients with heart failure: who, when, and why?. Eur Heart J Suppl 8: E32-E38 [Abstract] [Full Text]  
• Hankey, G. J. (2006). Potential New Risk Factors for Ischemic Stroke: What Is Their Potential?. Stroke 37: 2181-2188 [Abstract] [Full Text]  
• Hays, A. G., Sacco, R. L., Rundek, T., Sciacca, R. R., Jin, Z., Liu, R., Homma, S., Di Tullio, M. R. (2006). Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population. Stroke 37: 1715-1719 [Abstract] [Full Text]  
• Appelros, P. (2006). Heart Failure and Stroke. Stroke 37: 1637-1637 [Full Text]  
• Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L. (2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Circulation 113: e873-e923 [Abstract] [Full Text]  
• Cokkinos, D. V., Haralabopoulos, G. C., Kostis, J. B., Toutouzas, P. K., for the HELAS investigators, (2006). Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. Eur J Heart Fail 8: 428-432 [Abstract] [Full Text]  
• Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L. (2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Stroke 37: 1583-1633 [Abstract] [Full Text]  
• Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., Tomsick, T. (2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.. Circulation 113: e409-e449 [Abstract] [Full Text]  
• Sinha, A.-M., Skobel, E. C., Breithardt, O.-A., Zheng, H., Zhan, H., Wilcox, I., Booth, V., Lattimore, J., Chhajed, P. N., Tamm, M., Strobel, W., Neuberger, H.-R., Bohm, M., Mewis, C., Bradley, T. D., Floras, J. S., Logan, A. G., Yaggi, H. K., Concato, J., Mohsenin, V. (2006). Sleep apnea and heart disease.. NEJM 354: 1086-1089 [Full Text]  
• Blankfield, R. P. (2006). Can Natriuretic Peptide Levels Predict the Cardiovascular Complications of COX-2 Inhibitors and Nonsteroidal Anti-inflammatory Drugs?. J Am Board Fam Med 19: 178-182 [Abstract] [Full Text]  
• Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., Tomsick, T. (2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.. Stroke 37: 577-617 [Abstract] [Full Text]  
• Szummer, K. E., Solomon, S. D., Velazquez, E. J., Kilaru, R., McMurray, J., Rouleau, J.-L., Mahaffey, K. W., Maggioni, A. P., Califf, R. M., Pfeffer, M. A., White, H. D., on behalf of the VALIANT registry, (2005). Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry. Eur Heart J 26: 2114-2119 [Abstract] [Full Text]  
• Schafer, A., Fraccarollo, D., Eigenthaler, M., Tas, P., Firnschild, A., Frantz, S., Ertl, G., Bauersachs, J. (2005). Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of NO Bioavailability. Arterioscler. Thromb. Vasc. Bio. 25: 1071-1077 [Abstract] [Full Text]  
• Burger, P. C., Rocca, H. B.-L. (2005). Pharmacotherapy of Congestive Heart Failure in Elderly Patients. J CARDIOVASC PHARMACOL THER 10: 85-94 [Abstract]  
• Yan, A. T., Yan, R. T., Liu, P. P. (2005). Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials. ANN INTERN MED 142: 132-145 [Abstract] [Full Text]  
• Flemming, K. D., Brown, R. D. Jr (2004). Secondary Prevention Strategies in Ischemic Stroke: Identification and Optimal Management of Modifiable Risk Factors. Mayo Clin Proc. 79: 1330-1340 [Abstract]  
• Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., Teal, P. (2004). Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 483S-512S [Abstract] [Full Text]  
• Harrington, R. A., Becker, R. C., Ezekowitz, M., Meade, T. W., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H. (2004). Antithrombotic Therapy for Coronary Artery Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 513S-548S [Abstract] [Full Text]  
• Ho, J. E., Paultre, F., Mosca, L. (2003). Is Diabetes Mellitus a Cardiovascular Disease Risk Equivalent for Fatal Stroke in Women?: Data From the Women's Pooling Project. Stroke 34: 2812-2816 [Abstract] [Full Text]  
• Echemann, M., Alla, F., Briancon, S., Juilliere, Y., Virion, J.M., Mertes, P.M., Villemot, J.P., Zannad, F., EPICAL Investigators, (2002). Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study). Eur J Heart Fail 4: 647-654 [Abstract] [Full Text]  
• Straus, S. E., Majumdar, S. R., McAlister, F. A. (2002). New Evidence for Stroke Prevention: Scientific Review. JAMA 288: 1388-1395 [Abstract] [Full Text]  
• Lip, G.Y.H., Gibbs, C.R. (2002). Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. QJM 95: 451-459 [Abstract] [Full Text]  
• Lip, G.Y.H., Gibbs, C.R. (2002). Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. QJM 95: 461-468 [Abstract] [Full Text]  
• Zannad, F (2002). Evidence-based drug therapy for chronic heart failure. Eur Heart J Suppl 4: D66-D72 [Abstract]  
• Struthers, A D, Donnan, P T, Lindsay, P, McNaughton, D, Broomhall, J, MacDonald, T M (2002). Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 87: 229-234 [Abstract] [Full Text]  
• Tanne, D., Shotan, A., Goldbourt, U., Haim, M., Boyko, V., Adler, Y., Mandelzweig, L., Behar, S. (2002). Severity of Angina Pectoris and Risk of Ischemic Stroke. Stroke 33: 245-250 [Abstract] [Full Text]  
• Pullicino, P. M., Hart, J. (2001). Cognitive impairment in congestive heart failure?: Embolism vs hypoperfusion. Neurology 57: 1945-1946 [Full Text]  
• Task Force for the Diagnosis and Treatment of Chro, , Remme, W. J., Swedberg, K. (2001). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22: 1527-1560  
• Cleland, J.G.F., Thygesen, K., Uretsky, B.F., Armstrong, P., Horowitz, J.D., Massie, B., Packer, M., Poole-Wilson, P.A., Ryden, L., on behalf of the ATLAS investigators, (2001). Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J 22: 1601-1612 [Abstract]  
• Isnard, R., Komajda, M. (2001). Thromboembolism in heart failure, old ideas and new challenges. Eur J Heart Fail 3: 265-269 [Abstract] [Full Text]  
• Gibbs, C. R., Blann, A. D., Watson, R. D. S., Lip, G. Y. H. (2001). Abnormalities of Hemorheological, Endothelial, and Platelet Function in Patients With Chronic Heart Failure in Sinus Rhythm : Effects of Angiotensin-Converting Enzyme Inhibitor and {beta}-Blocker Therapy. Circulation 103: 1746-1751 [Abstract] [Full Text]  
• Cairns, J. A., Theroux, P., Lewis, H. D. Jr., Ezekowitz, M., Meade, T. W. (2001). Antithrombotic Agents in Coronary Artery Disease. Chest 119 : 228S-252S [Full Text]  
• Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., Teal, P. (2001). Antithrombotic and Thrombolytic Therapy for Ischemic Stroke. Chest 119 : 300S-320S [Full Text]  
• Brett, A. S., Meilof, J. F., Uitdehaag, B. M.I., Fruchter, O., White, H. D., Simes, R. J., Tonkin, A. M., The LIPID Study Group, (2000). Pravastatin Therapy and the Risk of Stroke. NEJM 343: 1894-1896 [Full Text]  
• Diet, F., Erdmann, E. (2000). Thromboembolism in heart failure: who should be treated?. Eur J Heart Fail 2: 355-363 [Abstract] [Full Text]  
• Lip, G. Y. H. (2000). Target Organ Damage and the Prothrombotic State in Hypertension. Hypertension 36: 975-977 [Full Text]  
• WIEGERS, S. E, SUTTON, M. S. J. (2000). When should ACE inhibitors or warfarin be discontinued after myocardial infarction?. Heart 84: 361-362 [Full Text]  
• Holloway, R. G., Benesch, C., Rush, S. R. (2000). Stroke prevention: Narrowing the evidence-practice gap. Neurology 54: 1899-1906 [Abstract] [Full Text]  
• Sharma, N. D., McCullough, P. A., Philbin, E. F., Weaver, W. D. (2000). Left Ventricular Thrombus and Subsequent Thromboembolism in Patients With Severe Systolic Dysfunction. Chest 117: 314-320 [Abstract] [Full Text]  
• Pullicino, P. M., Halperin, J. L., Thompson, J. L. P. (2000). Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology 54: 288-288 [Abstract] [Full Text]  
• Cokkinos, D. V., Toutouzas, P. K. (1999). Antithrombotic therapy in heart failure: a randomized comparison of warfarin vs. aspirin (HELAS). Eur J Heart Fail 1: 419-423 [Abstract] [Full Text]  
• Nadareishvili, Z. G., Choudary, Z., Joyner, C., Brodie, D., Norris, J. W. (1999). Cerebral Microembolism in Acute Myocardial Infarction. Stroke 30: 2679-2682 [Abstract] [Full Text]  
• Kapral, M. K., Silver, F. L. (1999). Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. CMAJ 161: 989-996 [Abstract] [Full Text]  
• Kelly, R., Struthers, A.D. (1999). Screening for left ventricular systolic dysfunction in patients with stroke, transient ischaemic attacks, and peripheral vascular disease. QJM 92: 295-297 [Full Text]  
• Davis, T. M. E., Millns, H., Stratton, I. M., Holman, R. R., Turner, R. C., for the UK Prospective Diabetes Study Group, (1999). Risk Factors for Stroke in Type 2 Diabetes Mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med 159: 1097-1103 [Abstract] [Full Text]  
• Mooe, T., Olofsson, B.-O., Stegmayr, B., Eriksson, P. (1999). Ischemic Stroke : Impact of a Recent Myocardial Infarction. Stroke 30: 997-1001 [Abstract] [Full Text]  
• Gorelick, P. B., Sacco, R. L., Smith, D. B., Alberts, M., Mustone-Alexander, L., Rader, D., Ross, J. L., Raps, E., Ozer, M. N., Brass, L. M., Malone, M. E., Goldberg, S., Booss, J., Hanley, D. F., Toole, J. F., Greengold, N. L., Rhew, D. C. (1999). Prevention of a First Stroke: A Review of Guidelines and a Multidisciplinary Consensus Statement From the National Stroke Association. JAMA 281: 1112-1120 [Abstract] [Full Text]  
• Plehn, J. F., Davis, B. R., Sacks, F. M., Rouleau, J. L., Pfeffer, M. A., Bernstein, V., Cuddy, T. E., Moye, L. A., Piller, L. B., Rutherford, J., Simpson, L. M., Braunwald, E. (1999). Reduction of Stroke Incidence After Myocardial Infarction With Pravastatin : The Cholesterol and Recurrent Events (CARE) Study. Circulation 99: 216-223 [Abstract] [Full Text]  
• Chen, C.-H., Nakayama, M., Nevo, E., Fetics, B. J., Maughan, W. L., Kass, D. A. (1998). Coupled systolic-ventricular and vascular stiffening with age: Implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 32: 1221-1227 [Abstract] [Full Text]  
• Wu, K. C., Zerhouni, E. A., Judd, R. M., Lugo-Olivieri, C. H., Barouch, L. A., Schulman, S. P., Blumenthal, R. S., Lima, J. A. C. (1998). Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction. Circulation 97: 765-772 [Abstract] [Full Text]  
• Oppenheimer, S. M, Lima, J. (1998). Neurology and the heart. J. Neurol. Neurosurg. Psychiatry 64: 289-297 [Full Text]  
• Delanty, N., Vaughan, C. J. (1997). Vascular Effects of Statins in Stroke. Stroke 28: 2315-2320 [Abstract] [Full Text]  
• Michaels, A. D., Gambassi, G., Carbonin, P., Bernabei, R., Loh, E., Moye, L. A., Pfeffer, M. A. (1997). Risk of Stroke after Myocardial Infarction. NEJM 336: 1916-1917 [Full Text]  
• (1997). Stroke After MI. Journal Watch Cardiology 1997: 4-4 [Full Text]  
• (1997). STROKE AFTER MYOCARDIAL INFARCTION. JWatch General 1997: 1-1 [Full Text]  
• Lichtman, J. H., Krumholz, H. M., Wang, Y., Radford, M. J., Brass, L. M. (2002). Risk and Predictors of Stroke After Myocardial Infarction Among the Elderly: Results From the Cooperative Cardiovascular Project. Circulation 105: 1082-1087 [Abstract] [Full Text]